Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

NCT01111955

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Farid Marquez, Md Hialeah, Florida, United States
  • Capital Clinical Reserch Center Olympia, Washington, United States
  • Aurora Advanced Healthcare Milwaukee, Wisconsin, United States
  • Local Institution Blacktown, New South Wales, Australia
View all 14 locations
View Trial Details
Completed

A Brief Intervention to Improve Medication Knowledge and Adherence Among Family Medicine Patients in South Texas

NCT00846300

Conditions
Behavior, Cardiovascular Diseases, Diabetes Mellitus, +15 more
Locations
  • Christus Memorial Hospital Corpus Christi, Texas, United States
  • Valley Baptist Family Medicine Residency Program Harlingen, Texas, United States
  • Laredo Medical Group Laredo, Texas, United States
  • McAllen Family Medicine Residency Program McAllen, Texas, United States
View Trial Details
Completed

A Study of LY2189265 in Japanese Patients With Type 2 Diabetes

NCT01001104

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan
View Trial Details
Completed

Evaluation of the Bioavailability of Pramlintide

NCT00042471

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Orlando Clinical Research Center Orlando, Florida, United States
  • New Orleans Center for Clinical Research New Orleans, Louisiana, United States
  • DaVita Clinical Research Minneapolis, Minnesota, United States
  • CEDRA Clinical Research, LLC Austin, Texas, United States
View Trial Details
Completed

Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes

NCT01774968

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mobile, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
View all 39 locations
View Trial Details

Related conditions